Phi Pharma is a private Swiss-based biopharmaceutical company. It specializes in the discovery and early clinical development of drug conjugates for improving treatment of diseases with high-medical need. Phi Pharma technology allows development of a powerful new class of peptide drug conjugates through specific cellular targeting and efficient